The AHA, Association of American Medical Colleges, America’s Essential Hospitals, 340B Health and three hospital systems today opposed the Department of Health and Human Services motion to stay in the groups’ lawsuit challenging the excessive delay in the effective date for the 340B price transparency rule.  

 

“Plaintiffs have been forced to wait more than eight years for the benefit of regulations required by Congress to protect them from overcharging by drug manufacturers,” the hospital groups’ memo said. “Defendants’ submission to OMB [Office of Management and Budget] of a proposed rule – without any assurance that the final 340B rule will actually be implemented by Jan. 1, 2019 – is not a basis for a stay, and defendants’ other arguments for delay are meritless.”

 

The memo also urges the court to order HHS to respond to the hospital groups’ “summary judgment motion within 7-10 days, to permit an expeditious resolution of plaintiffs’ claims.”

 

The AHA and other groups last month asked a federal court to order HHS to make effective within 30 days a final rule requiring drug companies to disclose the ceiling price for 340B outpatient drugs. To ensure accuracy and compliance with the 340B drug savings program, the rule also describes how ceiling prices must be calculated and would allow the federal government to levy civil monetary penalties against drug companies that intentionally overcharge 340B providers.

Related News Articles

Headline
The Alliance for Addiction Payment Reform, whose members include the AHA, today showcased its value-based payment model for addiction and recovery support…
Headline
The AHA is engaging in early primary states, including Nevada and South Carolina, with ads about affordability and rural health care to ensure issues…
Headline
The House Ways and Means Committee today favorably reported out, as amended, the Consumer Protections Against Surprise Medical Bills Act (H.R. 5826), AHA-…
Headline
The Campaign for Sustainable Rx Pricing today launched an ad campaign calling for Congress to pass bipartisan legislation to “hold Big Pharma accountable…
Headline
The Department of Health and Human Services today issued a proposed rule intended to clarify the rights and obligations of faith-based organizations…
Headline
The Health Resources and Services Administration should increase its oversight of private nonprofit hospitals that participate in the 340B drug savings program…